XML 48 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
12 Months Ended
Dec. 31, 2018
Income Taxes [Abstract]  
Income Taxes

17.  INCOME TAXES



Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the carrying amounts of existing assets and liabilities and their respective tax bases, and net operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted rates expected to be applicable to taxable income in the years those temporary differences are recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income during the period that includes the enactment date. The Tax Cuts and Jobs Act was enacted on December 22, 2017 and was effective January 1, 2018. Due to the significance of the legislation, the SEC issued Staff Accounting Bulletin 118 (SAB 118), which provides for a measurement period to complete the accounting for certain elements of the tax reform. We have completed the analysis of the legislation and its impact to the financial statements. The company has determined that the deductibility of certain officer compensation is now limited under the new legislation. The tax impact of $0.7 million for the amount that is not expected to be realized has been recorded to tax expense. This adjustment had an immaterial impact to the effective tax rate.



Green Plains Partners is a limited partnership, which is treated as a flow-through entity for federal income tax purposes and is not subject to federal income taxes. As a result, the consolidated financial statements do not reflect such income taxes on pre-tax income or loss attributable to the noncontrolling interest in the partnership.



Income tax expense (benefit) consists of the following (in thousands):





 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

Year Ended December 31,



 

2018

 

2017

 

2016

Current

 

$

7,758 

 

$

(43,705)

 

$

2,950 

Deferred

 

 

(24,484)

 

 

(81,077)

 

 

4,910 

Total

 

$

(16,726)

 

$

(124,782)

 

$

7,860 



The reduced benefit in 2018 compared to 2017 is primarily due to the company’s recognition of tax benefits related to enactment of the Tax Cuts and Jobs Act and for the completion of a multi-year study for Research and Development credits, or R&D Credits in 2017.



During the years ended December 31, 2018 and 2017, the company recognized a net income tax benefit of $19.6 million and $48.1 million, respectively, for federal and state R&D Credits. In addition, $2.3 million and $9.2 million, net, in refundable credits not dependent upon taxable income was recorded as a reduction of cost of goods sold during the years ended December 31, 2018 and 2017, respectively. R&D Credits recorded during 2017 related to tax years 2013 to 2016 as well as an estimated year-to-date tax benefit for federal and state R&D Credits for the 2017 tax year.



Differences between income tax expense at the statutory federal income tax rate and as presented on the consolidated statements of income are summarized as follows (in thousands):



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

Year Ended December 31,



2018

 

2017

 

2016

Tax expense at federal statutory rate

$

4,202 

 

$

(15,103)

 

$

13,423 

State income tax expense, net of federal benefit

 

981 

 

 

(915)

 

 

323 

Nondeductible compensation

 

921 

 

 

222 

 

 

185 

Noncontrolling interests

 

(4,370)

 

 

(7,199)

 

 

(6,940)

Unrecognized tax benefits

 

15,148 

 

 

25,720 

 

 

 -

R&D credits

 

(34,979)

 

 

(74,033)

 

 

 -

Disposition of subsidiary

 

(1,022)

 

 

 -

 

 

 -

Tax Cuts and Jobs Act impact

 

278 

 

 

(54,485)

 

 

 -

Stock compensation

 

993 

 

 

 -

 

 

 -

Audit adjustments

 

559 

 

 

 -

 

 

 -

Amended return adjustments

 

374 

 

 

 -

 

 

 -

Other

 

189 

 

 

1,011 

 

 

869 

Income tax expense (benefit)

$

(16,726)

 

$

(124,782)

 

$

7,860 

















 

 

 

 

 

 

 

 



Significant components of deferred tax assets and liabilities are as follows (in thousands):





 

 

 

 

 



 

 

 

 

 



December 31,



2018

 

2017

Deferred tax assets:

 

 

 

 

 

Net operating loss carryforwards - Federal

$

 -

 

$

12,767 

Net operating loss carryforwards - State

 

4,004 

 

 

5,291 

Tax credit carryforwards - Federal

 

47,956 

 

 

30,783 

Tax credit carryforwards - State

 

9,369 

 

 

5,342 

Derivative financial instruments

 

 -

 

 

2,592 

Deferred revenue

 

2,236 

 

 

919 

Interest expense carryforward

 

2,048 

 

 

 -

Investment in partnerships

 

50,009 

 

 

55,956 

Inventory valuation

 

3,603 

 

 

1,944 

Stock-based compensation

 

1,458 

 

 

2,468 

Accrued expenses

 

5,439 

 

 

5,541 

Capital leases

 

2,516 

 

 

2,426 

Other

 

43 

 

 

47 

Total deferred tax assets

 

128,681 

 

 

126,076 



 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Convertible debt

 

(7,508)

 

 

(8,350)

Fixed assets

 

(118,330)

 

 

(149,746)

Derivative financial instruments

 

(1,573)

 

 

 -

Organizational and start-up costs

 

(3,980)

 

 

(20,947)

Total deferred tax liabilities

 

(131,391)

 

 

(179,043)

Valuation allowance

 

(7,413)

 

 

(3,834)

Deferred income taxes

$

(10,123)

 

$

(56,801)



At December 31, 2018, the company has federal R&D credits of $48.0 million which will begin to expire in 2033. The company also has $9.4 million of state credits which will expire beginning in 2021.



The company has state net operating losses of $4.0 million which will begin to expire in 2022.  



The company maintains a valuation allowance for its net deferred tax assets due to uncertainty that it will realize these assets in the future. The deferred tax valuation allowance of $7.4 million as of December 31, 2018,  relates to state tax credits that are not expected to be realized prior to expiration starting in 2021. The deferred tax valuation allowance as of December 31, 2017 was $3.8 million. The increase in the deferred tax valuation allowance was primarily due to state R&D credits generated that are not expected to be realized prior to expiration. Management considers whether it is more likely than not that some or all of the deferred tax assets will be realized, which is dependent on the generation of future taxable income and other tax attributes during the periods those temporary differences become deductible. Scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies are considered to make this assessment.



The company’s federal and state returns for the tax years ended December 31, 2014, and later are still subject to audit. A reconciliation of unrecognized tax benefits is as follows (in thousands):





 

 



 

 

Unrecognized Tax Benefits

Balance at January 1, 2018

$

25,976 

Additions for prior year tax positions

 

5,980 

Additions for current year tax positions

 

20,922 

Settlements of prior year tax positions

 

(1,149)

Reductions for prior year tax positions

 

(171)

Balance at December 31, 2018

$

51,558 



Recognition of these tax benefits would favorably impact the company’s effective tax rate. Unrecognized tax benefits of $51.6 million include $40.8 million recorded as a reduction of the deferred asset associated with the federal tax credit carryforwards. Interest and penalties associated with uncertain tax positions are accrued as part of income taxes payable.